Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Sep 5;219(9):e20221183.
doi: 10.1084/jem.20221183. Epub 2022 Aug 16.

Helminths revive to survive

Affiliations
Comment

Helminths revive to survive

John R Grainger et al. J Exp Med. .

Abstract

Helminth parasites are well known to have co-evolved a diverse arsenal of immunomodulatory factors to aid their persistence following infection. In this issue, Karo-Atar et al. (2022. J. Exp. Med.https://doi.org/10.1084/jem.20212311) demonstrate that products released by the gut-dwelling helminth Heligmosomoides polygyrus barkeri modify intestinal stem cells into a "revival" state, which is associated with a loss of helminth-expelling secretory cell types from the epithelium.

PubMed Disclaimer

Figures

None
Insights from John R. Grainger and Rufus H. Daw.
None
Terminal differentiation of ISCs drives epithelial cell and secretory lineage repopulation of the intestinal villus at homeostasis. Following intestinal damage, for example during Hpb larval infiltration, IFN-γ–dependent fetal-like reversion of Sca-1+ ISCs occurs. Adult-stage Hpb infection in the intestinal lumen co-opts this type of response to intestinal damage via its ES products. The ES favors the differentiation of activated fetal-like Clu+ revSCs and reduces development of IL-4/IL-13 responsive immunologically involved epithelial cell lineages, such as goblet cells, important in worm expulsion. Created with BioRender.com.

Comment on

  • Helminth-induced reprogramming of the stem cell compartment inhibits type 2 immunity.
    Karo-Atar D, Ouladan S, Javkar T, Joumier L, Matheson MK, Merritt S, Westfall S, Rochette A, Gentile ME, Fontes G, Fonseca GJ, Parisien M, Diatchenko L, von Moltke J, Malleshaiah M, Gregorieff A, King IL. Karo-Atar D, et al. J Exp Med. 2022 Sep 5;219(9):e20212311. doi: 10.1084/jem.20212311. Epub 2022 Aug 8. J Exp Med. 2022. PMID: 35938990 Free PMC article.

References

    1. Asojo, O.A., et al. . 2018. Int. J. Parasitol. 10.1016/j.ijpara.2018.01.002 - DOI - PMC - PubMed
    1. Ayyaz, A., et al. . 2019. Nature. 10.1038/s41586-019-1154-y - DOI
    1. Bancroft, A.J., et al. . 2019. Nat. Commun. 10.1038/s41467-019-09996-z - DOI
    1. Broadhurst, M.J., et al. . 2010. Sci. Transl. Med. 10.1126/scitranslmed.3001500 - DOI - PubMed
    1. Coakley, G., and Harris N.L.. 2020. Trends Parasitol. 10.1016/j.pt.2020.07.002 - DOI - PubMed

Publication types